Glenmark Pharmaceuticals

BSE : 532296 | NSE : GLENMARK
Industry : Pharmaceuticals | ISIN : INE935A01035 | FreeFloat : 48.85% | FnO : Yes | LotSize : 1450
Intellectual Capital (IC)9,446.43
Net Worth (NW)10,226.96
Intrinsic Worth (IW)19,673.39
Market Cap (MC)11,968.16
Economic Value Added-119.80
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)48.02%
IC Gross Margin (EBITDA/IC)28.21%
IC Net Margin (NPT/IC)12.78%
Knowledge Turnover (Sales/IC)1.42
Market to Intrinsic Value (MC/IW)0.61
As OfIntrinsic ValueMarket Price
31 Dec 2022Rs. 697.22Rs. 424.15
20 Mar 2023 ---- Rs. 444.85
4.00     0.90%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 428.88BuyHold
KB > 50% : No50 DMA : Rs. 418.29
0 < M2IV < 1 : YesVol-Price trend : Rising
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-20
C
2767.49
2811.63
542.71
416.43
317.96
220.31
20.64
Jun-20
C
2344.79
2403.30
564.57
451.35
357.61
254.04
278.37
Sep-20
C
2952.48
2920.60
524.07
420.01
339.38
233.99
204.88
Dec-20
C
2786.76
2801.85
558.58
443.38
347.97
248.18
352.98
Mar-21
C
2859.90
2868.39
531.92
420.85
337.52
233.87
194.58
Jun-21
C
2964.90
3023.54
632.23
519.16
443.55
306.53
397.39
Sep-21
C
3147.45
3134.38
577.10
453.91
384.96
274.81
221.57
Dec-21
C
3173.41
3187.31
528.67
409.74
343.04
239.75
246.89
Mar-22
C
3019.15
3126.35
570.60
439.08
352.23
172.57
177.33
Jun-22
C
2777.29
2960.44
614.76
468.00
408.01
211.11
380.67
Sep-22
C
3375.25
3472.68
718.99
563.28
480.21
278.67
204.09
Dec-22
C
3463.86
3540.27
696.66
534.38
437.12
290.76
287.72
* C - Consolidated, S - Standalone